{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:15:12Z","timestamp":1771481712724,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS140497"],"award-info":[{"award-number":["R21NS140497"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["U54OD030167"],"award-info":[{"award-number":["U54OD030167"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["MD240021"],"award-info":[{"award-number":["MD240021"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hope4Gabe Foundation"},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["T32HD071866"],"award-info":[{"award-number":["T32HD071866"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K08NS120812"],"award-info":[{"award-number":["K08NS120812"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR066082"],"award-info":[{"award-number":["R01AR066082"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR079220"],"award-info":[{"award-number":["R01AR079220"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR064300"],"award-info":[{"award-number":["R01AR064300"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046096"],"award-info":[{"award-number":["R01DA046096"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01NS082413"],"award-info":[{"award-number":["R01NS082413"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029087","name":"Bernard F. and Alva B. Gimbel Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100029087","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09128-y","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T11:28:37Z","timestamp":1764674917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Conditional Dmd ablation in muscle and brain causes profound effects on muscle function and neurobehavior"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-9950","authenticated-orcid":false,"given":"Muthukumar","family":"Karuppasamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-5157","authenticated-orcid":false,"given":"Katherine G.","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8886-1475","authenticated-orcid":false,"given":"James R.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5640-9669","authenticated-orcid":false,"given":"Shelby N.","family":"Rorrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-0761","authenticated-orcid":false,"given":"Michael A.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-169X","authenticated-orcid":false,"given":"David K.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-5944","authenticated-orcid":false,"given":"Jodi R.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8601-4080","authenticated-orcid":false,"given":"Miguel A.","family":"Gutierrez-Monreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-8577","authenticated-orcid":false,"given":"Karen L.","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5791-1441","authenticated-orcid":false,"given":"Karyn A.","family":"Esser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5597-1141","authenticated-orcid":false,"given":"Jeffrey J.","family":"Widrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-0242","authenticated-orcid":false,"given":"Louis M.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-5171","authenticated-orcid":false,"given":"Matthew S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"9128_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","volume":"50","author":"M Koenig","year":"1987","unstructured":"Koenig, M. et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509\u2013517 (1987).","journal-title":"Cell"},{"key":"9128_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman, E. P., Brown, R. H. & Kunkel, L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919\u2013928 (1987).","journal-title":"Cell"},{"key":"9128_CR3","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield, G., Siller, W. G., Wight, P. A. & Moore, K. J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189\u20131192 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9128_CR4","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1126\/science.2662404","volume":"244","author":"P Sicinski","year":"1989","unstructured":"Sicinski, P. et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578\u20131580 (1989).","journal-title":"Science"},{"key":"9128_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JND-150113","volume":"3","author":"M Rodrigues","year":"2016","unstructured":"Rodrigues, M., Echigoya, Y., Fukada, S. -i & Yokota, T. Current translational research and murine models for duchenne muscular dystrophy. J. Neuromuscul. Dis. 3, 29\u201348 (2016).","journal-title":"J. Neuromuscul. Dis."},{"key":"9128_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67372-0","volume":"10","author":"A Bez Batti Angulski","year":"2020","unstructured":"Bez Batti Angulski, A. et al. Investigations of an inducible intact dystrophin gene excision system in cardiac and skeletal muscle in vivo. Sci. Rep. 10, 10967 (2020).","journal-title":"Sci. Rep."},{"key":"9128_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","volume":"238","author":"E Araki","year":"1997","unstructured":"Araki, E. et al. Targeted Disruption of Exon 52 in the Mouse Dystrophin Gene Induced Muscle Degeneration Similar to That Observed in Duchenne Muscular Dystrophy. Biochemical Biophysical Res. Commun. 238, 492\u2013497 (1997).","journal-title":"Biochemical Biophysical Res. Commun."},{"key":"9128_CR8","doi-asserted-by":"publisher","unstructured":"Saoudi, A. et al. Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy. Disease Models & Mechanisms 14. https:\/\/doi.org\/10.1242\/dmm.049028 (2021).","DOI":"10.1242\/dmm.049028"},{"key":"9128_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1078\/0344-0338-00058","volume":"197","author":"S Shibuya","year":"2001","unstructured":"Shibuya, S. et al. Muscle Plasma Membrane Changes in Dystrophin Gene Exon 52 Knockout Mouse. Pathol. - Res. Pract. 197, 441\u2013447 (2001).","journal-title":"Pathol. - Res. Pract."},{"key":"9128_CR10","doi-asserted-by":"publisher","unstructured":"Oliver, T. et al. The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease. Disease Models & Mechanisms 17. https:\/\/doi.org\/10.1242\/dmm.050397 (2024).","DOI":"10.1242\/dmm.050397"},{"key":"9128_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56644-w","volume":"16","author":"C Vaillend","year":"2025","unstructured":"Vaillend, C. et al. Duchenne muscular dystrophy: recent insights in brain related comorbidities. Nat. Commun. 16, 1298 (2025).","journal-title":"Nat. Commun."},{"key":"9128_CR12","doi-asserted-by":"publisher","unstructured":"Saoudi, A. et al. Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy. Disease Models & Mechanisms 17. https:\/\/doi.org\/10.1242\/dmm.050707 (2024).","DOI":"10.1242\/dmm.050707"},{"key":"9128_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102288","volume":"216","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto, Y. et al. Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy. Prog. Neurobiol. 216, 102288 (2022).","journal-title":"Prog. Neurobiol."},{"key":"9128_CR14","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.ajpath.2011.07.009","volume":"179","author":"N Beastrom","year":"2011","unstructured":"Beastrom, N. et al. mdx5cv Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice.  Am. J. Pathol. 179, 2464\u20132474 (2011).","journal-title":"Am. J. Pathol."},{"key":"9128_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/352536a0","volume":"352","author":"HH Stedman","year":"1991","unstructured":"Stedman, H. H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536\u2013539 (1991).","journal-title":"Nature"},{"key":"9128_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nmd.2011.04.012","volume":"22","author":"R Willmann","year":"2012","unstructured":"Willmann, R. et al. Enhancing translation: Guidelines for standard pre-clinical experiments in mdx mice. Neuromuscul. Disord. 22, 43\u201349 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"9128_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0960-8966(02)00191-8","volume":"13","author":"KE Wells","year":"2003","unstructured":"Wells, K. E. et al. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscul. Disord. 13, 21\u201331 (2003).","journal-title":"Neuromuscul. Disord."},{"key":"9128_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1172\/JCI36612","volume":"119","author":"Y Lai","year":"2009","unstructured":"Lai, Y. et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.  J. Clin. Investig. 119, 624\u2013635 (2009).","journal-title":"J. Clin. Investig."},{"key":"9128_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/mus.21764","volume":"42","author":"JA Call","year":"2010","unstructured":"Call, J. A., Mckeehen, J. N., Novotny, S. A. & Lowe, D. A. Progressive resistance voluntary wheel running in the mdx mouse. Muscle Nerve 42, 871\u2013880 (2010).","journal-title":"Muscle Nerve"},{"key":"9128_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/mus.25015","volume":"54","author":"KE Schill","year":"2016","unstructured":"Schill, K. E. et al. Muscle damage, metabolism, and oxidative stress in mdx mice: Impact of aerobic running. Muscle nerve 54, 110\u2013117 (2016).","journal-title":"Muscle nerve"},{"key":"9128_CR21","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont, N. A. et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat. Med 21, 1455\u20131463 (2015).","journal-title":"Nat. Med"},{"key":"9128_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41419-025-07755-1","volume":"16","author":"JA Granet","year":"2025","unstructured":"Granet, J. A. et al. Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity. Cell Death Dis. 16, 437 (2025).","journal-title":"Cell Death Dis."},{"key":"9128_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13682","volume":"16","author":"MarieE Esper","year":"2025","unstructured":"Esper, M. arieE. et al. Intrinsic Muscle Stem Cell Dysfunction Contributes to Impaired Regeneration in the mdx Mouse. J. Cachexia, Sarcopenia Muscle 16, e13682 (2025).","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"key":"9128_CR24","doi-asserted-by":"publisher","unstructured":"Chemello, F. et al. Degenerative and regenerative pathways underlying Duchenne muscular dystrophy revealed by single-nucleus RNA sequencing. Proceedings of the National Academy of Sciences, 202018391. https:\/\/doi.org\/10.1073\/pnas.2018391117 (2020).","DOI":"10.1073\/pnas.2018391117"},{"key":"9128_CR25","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1038\/tp.2016.174","volume":"6","author":"MS Alexander","year":"2016","unstructured":"Alexander, M. S. et al. Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A. Transl. Psychiatry 6, e901 (2016).","journal-title":"Transl. Psychiatry"},{"key":"9128_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105718","volume":"168","author":"MED Stefano","year":"2022","unstructured":"Stefano, M. E. D., Ferretti, V. & Mozzetta, C. Synaptic alterations as a neurodevelopmental trait of Duchenne muscular dystrophy. Neurobiol. Dis. 168, 105718 (2022).","journal-title":"Neurobiol. Dis."},{"key":"9128_CR27","first-page":"1041","volume":"26","author":"C Vaillend","year":"2017","unstructured":"Vaillend, C. & Chaussenot, R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum. Mol. Genet. 26, 1041\u20131055 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"9128_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1242\/dmm.018424","volume":"8","author":"JW McGreevy","year":"2015","unstructured":"McGreevy, J. W., Hakim, C. H., McIntosh, M. A. & Duan, D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis. Models Mechanisms 8, 195\u2013213 (2015).","journal-title":"Dis. Models Mechanisms"},{"key":"9128_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jcsm.13171","volume":"14","author":"CR Heier","year":"2023","unstructured":"Heier, C. R. et al. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45\u201347. J. Cachexia, Sarcopenia Muscle 14, 940\u2013954 (2023).","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"key":"9128_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-345","volume":"11","author":"M Ghahramani Seno","year":"2010","unstructured":"Ghahramani Seno, M. et al. Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization. BMC Genomics 11, 345 (2010).","journal-title":"BMC Genomics"},{"key":"9128_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75521","volume":"11","author":"MRF Gosselin","year":"2022","unstructured":"Gosselin, M. R. F. et al. Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts. eLife 11, e75521 (2022).","journal-title":"eLife"},{"key":"9128_CR32","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.celrep.2016.05.016","volume":"15","author":"InY Choi","year":"2016","unstructured":"Choi, I.nY. et al. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model. Cell Rep. 15, 2301\u20132312 (2016).","journal-title":"Cell Rep."},{"key":"9128_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-020-00224-7","volume":"10","author":"L Caputo","year":"2020","unstructured":"Caputo, L. et al. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGF\u03b2-dependent pro-fibrotic signaling. Skelet. Muscle 10, 13 (2020).","journal-title":"Skelet. Muscle"},{"key":"9128_CR34","doi-asserted-by":"publisher","unstructured":"Massenet, J. et al. Epigenetic control of myogenic identity of human muscle stem cells in Duchenne Muscular Dystrophy. bioRxiv, 2023.2004.2026.538414. https:\/\/doi.org\/10.1101\/2023.04.26.538414 (2023).","DOI":"10.1101\/2023.04.26.538414"},{"key":"9128_CR35","doi-asserted-by":"publisher","first-page":"e202402831","DOI":"10.26508\/lsa.202402831","volume":"8","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. PTPN1\/2 inhibition promotes muscle stem cell differentiation in Duchenne muscular dystrophy. Life Sci. Alliance 8, e202402831 (2025).","journal-title":"Life Sci. Alliance"},{"key":"9128_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ymthe.2020.09.029","volume":"29","author":"F Yue","year":"2021","unstructured":"Yue, F. et al. PTEN Inhibition Ameliorates Muscle Degeneration and Improves Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy. Mol. Ther. 29, 132\u2013148 (2021).","journal-title":"Mol. Ther."},{"key":"9128_CR37","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1172\/JCI73579","volume":"124","author":"MS Alexander","year":"2014","unstructured":"Alexander, M. S. et al. MicroRNA-486\u2013dependent modulation of DOCK3\/PTEN\/AKT signaling pathways improves muscular dystrophy\u2013associated symptoms.  J. Clin. Investig. 124, 2651\u20132667 (2014).","journal-title":"J. Clin. Investig."},{"key":"9128_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2019.01.002","author":"YX Wang","year":"2019","unstructured":"Wang, Y. X. et al. EGFR-Aurka Signaling Rescues Polarity and Regeneration Defects in Dystrophin-Deficient Muscle Stem Cells by Increasing Asymmetric Divisions. Cell Stem Cell https:\/\/doi.org\/10.1016\/j.stem.2019.01.002 (2019).","journal-title":"Cell Stem Cell"},{"key":"9128_CR39","doi-asserted-by":"publisher","unstructured":"Kodippili, K. & Rudnicki, M.A. Satellite cell contribution to disease pathology in Duchenne muscular dystrophy. Frontiers in Physiology 14. https:\/\/doi.org\/10.3389\/fphys.2023.1180980 (2023).","DOI":"10.3389\/fphys.2023.1180980"},{"key":"9128_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.24.577041","author":"U Gurriaran-Rodriguez","year":"2024","unstructured":"Gurriaran-Rodriguez, U. et al. Wnt7a is Required for Regeneration of Dystrophic Skeletal Muscle. bioRxiv https:\/\/doi.org\/10.1101\/2024.01.24.577041 (2024).","journal-title":"bioRxiv"},{"key":"9128_CR41","doi-asserted-by":"publisher","unstructured":"Ortuste Quiroga, H.P., Fujimaki, S. & Ono, Y. Pax7 reporter mouse models: a pocket guide for satellite cell research. Eur J Transl Myol 33. https:\/\/doi.org\/10.4081\/ejtm.2023.12174 (2023).","DOI":"10.4081\/ejtm.2023.12174"},{"key":"9128_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32163-w","volume":"13","author":"A Lindsay","year":"2023","unstructured":"Lindsay, A. & Russell, A. P. The unconditioned fear response in dystrophin-deficient mice is associated with adrenal and vascular function. Sci. Rep. 13, 5513 (2023).","journal-title":"Sci. Rep."},{"key":"9128_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nlm.2015.07.006","volume":"124","author":"R Chaussenot","year":"2015","unstructured":"Chaussenot, R. et al. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes. Neurobiol. Learn. Mem. 124, 111\u2013122 (2015).","journal-title":"Neurobiol. Learn. Mem."},{"key":"9128_CR44","doi-asserted-by":"publisher","unstructured":"Gharibi, S., Vaillend, C. & Lindsay, A. The unconditioned fear response in vertebrates deficient in dystrophin. Progress in Neurobiology, 102590. https:\/\/doi.org\/10.1016\/j.pneurobio.2024.102590 (2024).","DOI":"10.1016\/j.pneurobio.2024.102590"},{"key":"9128_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-015-0053-9","volume":"6","author":"R Miranda","year":"2015","unstructured":"Miranda, R. et al. Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy. Mol. Autism 6, 60 (2015).","journal-title":"Mol. Autism"},{"key":"9128_CR46","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052047","author":"MAT Verhaeg","year":"2025","unstructured":"Verhaeg, M. A. T. et al. Behavioral characterization of the mdx5cv, mdx52 and DMD-null mouse models of Duchenne muscular dystrophy. Dis. Models Mechanisms https:\/\/doi.org\/10.1242\/dmm.052047 (2025).","journal-title":"Dis. Models Mechanisms"},{"key":"9128_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.beproc.2017.05.012","volume":"142","author":"M Lewon","year":"2017","unstructured":"Lewon, M. et al. Evaluation of the behavioral characteristics of the mdx mouse model of duchenne muscular dystrophy through operant conditioning procedures. Behavioural Process. 142, 8\u201320 (2017).","journal-title":"Behavioural Process."},{"key":"9128_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-01996-z","volume":"13","author":"F Catapano","year":"2025","unstructured":"Catapano, F. et al. A comprehensive spatiotemporal map of dystrophin isoform expression in the developing and adult human brain. Acta Neuropathologica Commun. 13, 110 (2025).","journal-title":"Acta Neuropathologica Commun."},{"key":"9128_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12981-5","volume":"7","author":"N Doorenweerd","year":"2017","unstructured":"Doorenweerd, N. et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci. Rep. 7, 12575 (2017).","journal-title":"Sci. Rep."},{"key":"9128_CR50","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/brain\/awae384","volume":"148","author":"K Tetorou","year":"2024","unstructured":"Tetorou, K., Aghaeipour, A., Singh, S., Morgan, J. E. & Muntoni, F. The role of dystrophin isoforms and interactors in the brain. Brain 148, 1081\u20131098 (2024).","journal-title":"Brain"},{"key":"9128_CR51","doi-asserted-by":"publisher","first-page":"0149","DOI":"10.1523\/ENEURO.0149-24.2024","volume":"11","author":"JN Jahncke","year":"2024","unstructured":"Jahncke, J. N. & Wright, K. M. Tools for Cre-Mediated Conditional Deletion of Floxed Alleles from Developing Cerebellar Purkinje Cells. eneuro 11, 0149\u20130124 (2024). ENEURO.","journal-title":"eneuro"},{"key":"9128_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JND-221586","volume":"10","author":"C Pascual-Morena","year":"2023","unstructured":"Pascual-Morena, C. et al. Dystrophin Genotype and Risk of Neuropsychiatric Disorders in Dystrophinopathies: A Systematic Review and Meta-Analysis. J. Neuromuscul. Dis. 10, 159\u2013172 (2023).","journal-title":"J. Neuromuscul. Dis."},{"key":"9128_CR53","doi-asserted-by":"publisher","first-page":"e1597","DOI":"10.1212\/WNL.0000000000008363","volume":"93","author":"M Thangarajh","year":"2019","unstructured":"Thangarajh, M. et al. Relationships between DMD mutations and neurodevelopment in dystrophinopathy. Neurology 93, e1597\u2013e1604 (2019).","journal-title":"Neurology"},{"key":"9128_CR54","doi-asserted-by":"publisher","unstructured":"Thangarajh, M. et al. Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DNHS). PLoS Curr. 10, https:\/\/doi.org\/10.1371\/currents.md.4cdeb6970e54034db2bc3dfa54b4d987 (2018).","DOI":"10.1371\/currents.md.4cdeb6970e54034db2bc3dfa54b4d987"},{"key":"9128_CR55","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1523\/JNEUROSCI.1256-21.2022","volume":"42","author":"W-C Wu","year":"2022","unstructured":"Wu, W.-C., Bradley, S. P., Christie, J. M. & Pugh, J. R. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.  J. Neurosci. 42, 2103\u20132115 (2022).","journal-title":"J. Neurosci."},{"key":"9128_CR56","doi-asserted-by":"publisher","unstructured":"Stay, T.L., Miterko, L.N., Arancillo, M., Lin, T. & Sillitoe, R.V. In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy. Disease Models & Mechanisms, dmm.040840. https:\/\/doi.org\/10.1242\/dmm.040840 (2019).","DOI":"10.1242\/dmm.040840"},{"key":"9128_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ana.26409","volume":"92","author":"F Zarrouki","year":"2022","unstructured":"Zarrouki, F. et al. Partial Restoration of Brain Dystrophin and Behavioral Deficits by Exon Skipping in the Muscular Dystrophy X-Linked (mdx) Mouse. Ann. Neurol. 92, 213\u2013229 (2022).","journal-title":"Ann. Neurol."},{"key":"9128_CR58","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/mt.2010.134","volume":"18","author":"C Vaillend","year":"2010","unstructured":"Vaillend, C. et al. Rescue of a Dystrophin-like Protein by Exon Skipping In Vivo Restores GABAA-receptor Clustering in the Hippocampus of the mdx Mouse. Mol. Ther. 18, 1683\u20131688 (2010).","journal-title":"Mol. Ther."},{"key":"9128_CR59","doi-asserted-by":"publisher","unstructured":"Wang, C., Yue, F. & Kuang, S. Muscle Histology Characterization Using H&E Staining and Muscle Fiber Type Classification Using Immunofluorescence Staining. Bio Protoc 7. https:\/\/doi.org\/10.21769\/BioProtoc.2279 (2017).","DOI":"10.21769\/BioProtoc.2279"},{"key":"9128_CR60","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.76478","volume":"11","author":"LA Riley","year":"2022","unstructured":"Riley, L. A. et al. The skeletal muscle circadian clock regulates titin splicing through RBM20. eLife 11, e76478 (2022).","journal-title":"eLife"},{"key":"9128_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-016-0082-x","volume":"6","author":"BD Harfmann","year":"2016","unstructured":"Harfmann, B. D. et al. Muscle-specific loss of Bmal1 leads to disrupted tissue glucose metabolism and systemic glucose homeostasis. Skelet. Muscle 6, 12 (2016).","journal-title":"Skelet. Muscle"},{"key":"9128_CR62","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/hmg\/ddaa173","volume":"29","author":"AL Reid","year":"2020","unstructured":"Reid, A. L. et al. DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies. Hum. Mol. Genet. 29, 2855\u20132871 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"9128_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nmd.2011.08.001","volume":"22","author":"YM Kobayashi","year":"2012","unstructured":"Kobayashi, Y. M., Rader, E. P., Crawford, R. W. & Campbell, K. P. Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies. Neuromuscul. Disord. 22, 34\u201342 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"9128_CR64","doi-asserted-by":"crossref","unstructured":"Yang, M., Silverman, J.L. & Crawley, J.N. Automated Three-Chambered Social Approach Task for Mice. In Current Protocols in Neuroscience, (John Wiley & Sons, Inc) (2011).","DOI":"10.1002\/0471142301.ns0826s56"},{"key":"9128_CR65","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/BF02327580","volume":"25","author":"C Vaillend","year":"1995","unstructured":"Vaillend, C., Rendon, A., Misslin, R. & Ungerer, A. Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks. Behav. Genet 25, 569\u2013579 (1995).","journal-title":"Behav. Genet"},{"key":"9128_CR66","doi-asserted-by":"publisher","unstructured":"Engelbeen, S., Aartsma-Rus, A., Koopmans, B., Loos, M. & van Putten, M. Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy. Frontiers in Behavioral Neuroscience 14. https:\/\/doi.org\/10.3389\/fnbeh.2020.629043 (2021).","DOI":"10.3389\/fnbeh.2020.629043"},{"key":"9128_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12895","volume":"23","author":"M Verhaeg","year":"2024","unstructured":"Verhaeg, M. et al. Learning, memory and blood\u2013brain barrier pathology in Duchenne muscular dystrophy mice lacking Dp427, or Dp427 and Dp140. Genes, Brain Behav. 23, e12895 (2024).","journal-title":"Genes, Brain Behav."},{"key":"9128_CR68","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees, C. V. & Williams, M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848\u2013858 (2006).","journal-title":"Nat. Protoc."},{"key":"9128_CR69","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","volume":"28","author":"J K\u00f6ster","year":"2012","unstructured":"K\u00f6ster, J. & Rahmann, S. Snakemake\u2014a scalable bioinformatics workflow engine. Bioinformatics 28, 2520\u20132522 (2012).","journal-title":"Bioinformatics"},{"key":"9128_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"9128_CR71","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09128-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:02:46Z","timestamp":1764680566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09128-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9128"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09128-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.M.K. is a consultant for Pfizer, Dyne Therapeutics, and Myofinity for muscle disease drug therapies. M.S.A. is on the Solid Biosciences Advisory Board. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1736"}}